Prograf + MR4

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
77
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Kidney Transplantation

Conditions

Kidney Transplantation

Trial Timeline

Feb 1, 2006 โ†’ Mar 1, 2008

About Prograf + MR4

Prograf + MR4 is a phase 3 stage product being developed by Astellas Pharma for Kidney Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00720265. Target conditions include Kidney Transplantation.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT00720265Phase 3Completed
NCT00719745Phase 3Completed

Competing Products

20 competing products in Kidney Transplantation

See all competitors